← Back to Search

Single arm for Type 1 Diabetes

N/A
Waitlist Available
Research Sponsored by University of Illinois at Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* Adults 18-50 years with a clinical diagnosis of T1D for at least one year
* Report habitual sleep irregularity ≥1 hour/week
Timeline
Screening 3 weeks
Treatment Varies
Follow Up enrollment to week 12
Awards & highlights

Summary

People with type 1 diabetes are disproportionately affected by cardiovascular disease (CVD). Short and irregular sleep have been associated with cardiovascular risk in this population. Improving sleep regularity has been associated with improved glycemic markers however mechanisms by which improving sleep regularity improves metabolic and cardiovascular health is not known. The investigators propose to conduct a mechanistic study using a sleep stability manipulation. This proposal will advance the understanding of mechanisms by which improving sleep regularity influences glycemic control and cardiovascular risk in T1D.

Eligible Conditions
  • Type 1 Diabetes

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~enrollment to week 12
This trial's timeline: 3 weeks for screening, Varies for treatment, and enrollment to week 12 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Glycemic control
Glycemic status
Insulin sensitivity
Secondary study objectives
Cardiovascular outcome CIMT
Cardiovascular outcome arterial stiffness
Cardiovascular outcome blood pressure
+8 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Single armExperimental Treatment1 Intervention
Sleep stability intervention

Find a Location

Who is running the clinical trial?

University of Illinois at ChicagoLead Sponsor
636 Previous Clinical Trials
1,568,600 Total Patients Enrolled
National Institutes of Health (NIH)NIH
2,788 Previous Clinical Trials
8,139,834 Total Patients Enrolled
~53 spots leftby Mar 2029